PharmAthene Inc. – NYSE MKT: PIP

This is another stock creating a new 52 week high just days ago. At $2.42 last week, you would have to go back to 2011 to see higher levels.

Why?

I think part of the reason for the recent surge is this article by Jeff Eiseman at Seeking Alpha: “How PharmAthene And Theraclone’s Assets Will Enhance Shareholder Value”

I am not going to copy over his rationale to this article. I will just say this: I read this when it came out and noticed the stock immediately went on and set these new 52 week highs after that. Read Mr. Eiseman’s rationale, and I am sold after reading it. (Link to his article in the sources section at the end of this article.)

 

 

 

SEE PIP IN STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS

SEE THE ENTIRE LIST OF STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS